Evidence map›Paper›PMID 33067472›Full record

ArticleNature communications2020

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19.

Guillaume Carissimo, Weili Xu, Immanuel Kwok, Mohammad Yazid Abdad, Yi-Hao Chan, Siew-Wai Fong, Kia Joo Puan, Cheryl Yi-Pin Lee, Nicholas Kim-Wah Yeo, Siti Naqiah Amrun and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 195 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Guillaume CarissimoInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore. guillaume_carissimo@immunol.a-star.edu.sg.ORCID 0000-0002-9703-9096
Weili XuSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Immanuel KwokSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Mohammad Yazid AbdadNational Centre for Infectious Diseases, 16 Jalan Tan Tock Seng, 308442, Singapore, Singapore.ORCID 0000-0001-7772-9148
Yi-Hao ChanInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.ORCID 0000-0003-0329-238X
Siew-Wai FongInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Kia Joo PuanSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.ORCID 0000-0003-2445-3154
Cheryl Yi-Pin LeeInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Nicholas Kim-Wah YeoInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Siti Naqiah AmrunInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Rhonda Sin-Ling CheeInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Wilson HowSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Stephrene ChanDepartment of Haematology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore, Singapore.
Bingwen Eugene FanDepartment of Haematology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 308433, Singapore, Singapore.ORCID 0000-0003-4367-5182
Anand Kumar AndiappanSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.ORCID 0000-0002-8442-1544
Bernett LeeSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Olaf RötzschkeSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Barnaby Edward YoungNational Centre for Infectious Diseases, 16 Jalan Tan Tock Seng, 308442, Singapore, Singapore.ORCID 0000-0003-1010-2230
Yee-Sin LeoNational Centre for Infectious Diseases, 16 Jalan Tan Tock Seng, 308442, Singapore, Singapore.ORCID 0000-0003-4978-5825
David Chien LyeNational Centre for Infectious Diseases, 16 Jalan Tan Tock Seng, 308442, Singapore, Singapore.
Laurent ReniaInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.ORCID 0000-0003-0349-1557
Lai Guan NgSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.ORCID 0000-0003-1905-3586
Anis LarbiSingapore Immunology Network, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore.
Lisa Fp NgInfectious Disease Horizontal Technology Center, Agency for Science, Technology and Research, Immunos, Biopolis, 138648, Singapore. lisa_ng@immunol.a-star.edu.sg.ORCID 0000-0003-4071-5222
Agency for Science, Technology and Research · SGNanyang Technological University · SGTan Tock Seng Hospital · SGNational Centre for Infectious Diseases · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 is the novel coronavirus responsible for the current COVID-19 pandemic. Severe complications are observed only in a small proportion of infected patients but the cellular mechanisms underlying this progression are still unknown. Comprehensive flow cytometry of whole blood samples from 54 COVID-19 patients reveals a dramatic increase in the number of immature neutrophils. This increase strongly correlates with disease severity and is associated with elevated IL-6 and IP-10 levels, two key players in the cytokine storm. The most pronounced decrease in cell counts is observed for CD8 T-cells and VD2 γδ T-cells, which both exhibit increased differentiation and activation. ROC analysis reveals that the count ratio of immature neutrophils to VD2 (or CD8) T-cells predicts pneumonia onset (0.9071) as well as hypoxia onset (0.8908) with high sensitivity and specificity. It would thus be a useful prognostic marker for preventive patient management and improved healthcare resource management.

Indexed as

BetacoronavirusBiomarkersCD8-Positive T-LymphocytesCoronavirus InfectionsCOVID-19Cytokine Release SyndromeFlow CytometryHumansImmunophenotypingInterleukin-10Interleukin-6Lymphocyte CountNeutrophilsPandemicsPneumonia, ViralReceptors, Antigen, T-Cell, gamma-deltaBiomarkersIL10 protein, humanIL6 protein, humanInterleukin-10Interleukin-6Receptors, Antigen, T-Cell, gamma-delta

Identifiers

PMID33067472
PMCPMC7568554
OpenAlexW3092817099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.